Episode #6: Real World Evidence

There has been an increase of access to data and different types of health data available. It's widely believed that Real World Data (RWD) has the ability to drive efficiency and business value. C-suite leaders in pharmaceutical companies increasingly view Real World Evidence (RWE) as strategically important. Equally a knowledge management system is a critical capability needed to maximise RWD.

In the sixth episode of Life Sciences Connect, we explore how best to implement knowledge management to maximise RWD, the role skills and talent has in maximising value from RWD and the challenges the industry faces in accessing such talent.

This episode is led by our host Karen Taylor. Karen is joined by Meri Petrovska, the Knowledge Management Director at AstraZeneca and Seb Burnett, the General Manager of ConvergeHEALTH by Deloitte Europe.

This episode explores:

• the impact of RWE on biopharma companies;

• implementing knowledge management systems to maximise Real World Data (RWD)

• the importance of change management 
• the role of skills and talent in maximising value from RWD and the challenges the industry faces in accessing such talent